Updated modelling of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters
Authors:
Open Access
- 24 October 2019
- journal article
- research article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 147, e295
Abstract
Conditions and evidence continue to evolve related to the prediction of the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus (iVDPV) excreters, which affect assumptions related to forecasting risks and evaluating potential risk management options. Multiple recent reviews provided information about individual iVDPV excreters, but inconsistencies among the reviews raise some challenges. This analysis revisits the available evidence related to iVDPV excreters and provides updated model estimates that can support future risk management decisions. The results suggest that the prevalence of iVDPV excreters remains highly uncertain and variable, but generally confirms the importance of managing the risks associated with iVDPV excreters throughout the polio endgame in the context of successful cessation of all oral poliovirus vaccine use.Keywords
This publication has 50 references indexed in Scilit:
- Characteristics of an Environmentally Monitored Prolonged Type 2 Vaccine Derived Poliovirus Shedding Episode that Stopped without InterventionPLOS ONE, 2013
- Role of environmental poliovirus surveillance in global polio eradication and beyondEpidemiology and Infection, 2011
- Pathways Of Health Technology Diffusion: The United States And Low-Income CountriesHealth Affairs, 2009
- The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008Clinical and Experimental Immunology, 2009
- Common variable immunodeficiency disorders: division into distinct clinical phenotypesBlood, 2008
- Containment of Polioviruses After Eradication and OPV Cessation: Characterizing Risks to Improve ManagementRisk Analysis, 2006
- Risks of Paralytic Disease Due to Wild or Vaccine‐Derived Poliovirus After EradicationRisk Analysis, 2006
- Vaccine-derived poliovirus from long term excretors and the end game of polio eradicationBiologicals, 2006
- Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and ImmunologyJournal of Allergy and Clinical Immunology, 2006
- Duration of Poliovirus Excretion and Its Implications for Acute Flaccid Paralysis Surveillance: A Review of the LiteratureThe Journal of Infectious Diseases, 1997